Bronstein, Gewirtz & Grossman LLC Urges Varonis Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Varonis Investors to Explore Class Action Representation GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a […]

Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges agilon Investors to Explore Class Action Representation GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Bronstein, Gewirtz & Grossman LLC Urges SLM Corporation a/k/a Sallie Mae Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges SLM Investors to Explore Class Action Representation GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces

Bronstein, Gewirtz & Grossman LLC Urges Klarna Group plc Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Klarna Investors to Explore Class Action Representation GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Important Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf GlobeNewswire January 09, 2026 PHILADELPHIA, Jan. 09, 2026 (GLOBE NEWSWIRE) — Integer Holdings Corp. (NYSE: ITGR): Grabar Law Office is investigating

LECTRA: Monthly declaration of the total number of shares and voting rights composing the company's capital (at December 31st, 2025) GlobeNewswire January 09, 2026 Monthly declaration of the total number of shares and voting rights composing the company's capital (at December 31st, 2025) This declaration is established in accordance with Article L.233-8 II of the

(NASDAQ:TLX), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired Telix securities between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights GlobeNewswire January 09, 2026 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options If you purchased

(CNSX:DRUG.CN),(CNSX:DRUG),(NASDAQ:DRUG), NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company“) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares“) at a price of US$90.00 per Common Share for gross proceeds of US$175,050,000

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company“) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares“)